Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
Abstract The two main objectives of this analysis were to (i) characterize the relationship between immunoglobulin (Ig) exposure and chronic inflammatory demyelinating polyneuropathy (CIDP) disease severity using data from 171 patients with CIDP who received either subcutaneous Ig (IgPro20; Hizentra...
Saved in:
Main Authors: | Michael A. Tortorici (Author), Theresa Yuraszeck (Author), David Cornblath (Author), Vera Bril (Author), Hans‐Peter Hartung (Author), Gen Sobue (Author), Richard A. Lewis (Author), Ingemar S. J. Merkies (Author), John‐Philip Lawo (Author), Michaela Praus (Author), Billie L. Durn (Author), Orell Mielke (Author), Xuewen Ma (Author), Petra Jauslin (Author), Marc Pfister (Author), Ivo N. vanSchaik (Author), the PATH study group (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subacute Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005) -
Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010) -
Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005) -
Animal models of immune-mediated demyelinating polyneuropathies
by: Eroboghene E. Ubogu
Published: (2024) -
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT
by: А.L. Kurenkov, et al.
Published: (2014)